凤凰网首页 手机凤凰网

凤凰卫视
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
免费注册
上海医药(601607)公告正文

上海医药:2008年第一季度报告

公告日期 2008-04-26
股票简称:上海医药 股票代码:601607
证券代码:600849 证券简称:上海医药 
上海市医药股份有限公司2008年第一季度报告

    1重要提示
    1.1本公司董事会、监事会及其董事、监事、高级管理人员保证本报告所载资料不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。
    1.2公司全体董事出席董事会会议。
    1.3公司第一季度财务报告未经审计。
    1.4公司董事长钱◇先生、总经理余金琦女士、财务副总监许薇薇女士声明:保证本季度报告中财务报告的真实、完整。
    2公司基本情况
    2.1主要会计数据及财务指标

                                                                                币种:人民币
                                                                                本报告期末
                                             本报告期末         上年度期末      比上年度期
                                                                                 末增减(%)
 总资产(元)                               7,951,061,831.19   7,125,598,333.22         11.58
 所有者权益(或股东权益)(元)             1,665,681,701.80  1,641,417,114.92           1.48
 归属于上市公司股东的每股净资产(元)                   2.93               2.88          1.48
                                              年初至报告期期末          比上年同期增减(%)
 经营活动产生的现金流量净额(元)                     -78,844,905.87                   -59.64
 每股经营活动产生的现金流量净额(元)                           -0.14                  -59.64
                                                                              本报告期比上
                                                            年初至报告期期
                                               报告期                              年
                                                                   末
                                                                               同期增减(%)
 归属于上市公司股东的净利润(元)              25,405,810.56    25,405,810.56             0.79
 基本每股收益(元)                                     0.04             0.04          -16.01
 扣除非经常性损益后基本每股收益(元)                   0.04             0.04           24.55
 稀释每股收益(元)                                     0.04             0.04           -16.01
                                                                              减少0.02个百
 全面摊薄净资产收益率(%)                              1.53             1.53
                                                                                       分点
 扣除非经常性损益后全面摊薄净资产收益                                         增加0.48个百
                                                      1.52             1.52
 率(%)                                                                                 分点
                     非经常性损益项目                          年初至报告期期末金额(元)
 非流动资产处置损益                                                                6,525.94
 计入当期损益的政府补助,但与公司业务密切相关,按照国家
                                                                                 206,654.63
 统一标准定额或定量享受的政府补助除外
 与公司主营业务无关的预计负债产生的损益                                          -59,288.49
 合计                                                                            153,892.08

    注:①在基本每股收益的计算中,本报告期每股收益是以2007年8月实施资本公积10股转增2股后的总股本569,172,884股为计算口径,与上年同期每股收益以总股本474,310,737计算非同一口径。
    2.2报告期末股东总人数及前十名无限售条件股东持股情况表

                                                                                    单位:股
 报告期末股东总数(户)                                                              68,635
                            前十名无限售条件流通股股东持股情况
                                                           期末持有无限售条
                     股东名称(全称)                                                种类
                                                             件流通股的数量
 中国工商银行-华安中小盘成长股票型证券投资基金                     25700000   人民币普通股
 中国建设银行-鹏华价值优势股票型证券投资基金                       18132904   人民币普通股
 中国工商银行-鹏华优质治理股票型证券投资基金(LOF)                   7630550   人民币普通股
 中国太平洋人寿保险股份有限公司-分红-个人分红                      7600000   人民币普通股
 中国建设银行-交银施罗德稳健配置混合型证券投资基金                  6988524   人民币普通股
 中国太平洋人寿保险股份有限公司-传统-普通保险产品                  5118279   人民币普通股
 全国社保基金一零二组合                                              4800000   人民币普通股
 华夏银行股份有限公司-益民红利成长混合型证券投资基金                3819292   人民币普通股
 中国太平洋保险(集团)股份有限公司-集团本级-自有资金
                                                                     3600000   人民币普通股
 -012G-ZY001沪
 北京奥通达投资咨询有限公司                                          3558060   人民币普通股

    3重要事项
    3.1公司主要会计报表项目、财务指标大幅度变动的情况及原因
    √适用□不适用
    1、截至报告期末,资产负债表项目大幅度变动原因分析:

   项目      2008年3月31日       2007年12月31日            增减额        增减比例
 货币资金       871,819,029.34        629,403,713.66     242,415,315.68     38.52%
 应收账款     2,897,111,068.22      2,214,456,718.25     682,654,349.97     30.83%
其他应付款      518,664,120.46        214,260,630.74     304,403,489.72    142.07%

    ⑴货币资金比年初上升38.52%,主要原因系①采用贸易融资产品汇利达所致②季末回笼较多;
    ⑵应收账款比年初上升30.83%,主要原因系本期销售同比增加幅度较大所致;
    ⑶其他应付款比年初上升142.07%,主要原因系①采用贸易融资产品汇利达所致②沪中合资股权转让未结算③天津房产转让款未结算。
    2、报告期内,利润表项目大幅度变动原因分析:

   项目       2008年1-3月         2007年1-3月            增减额        增减比例
  毛利额        362,734,424.08        256,129,635.31     106,604,788.77     41.62%
 销售费用       201,925,287.92        120,105,342.38      81,819,945.54     68.12%
投资净收益        3,202,177.91         11,308,065.37      -8,105,887.46    -71.68%

    ⑴毛利额同比上升41.62,主要系①销售增长幅度较大②供应商折让方式变化③去年同期比较数中未含华氏大药房;
    ⑵销售费用比上升68.12%,主要系①去年同期比较数中未含华氏大药房②本期销售规模增长③供应商价格折让成本化(去年同期为费用化)④预提市场开发费;
    ⑶同比下降71.68%,主要系下属子公司二级市场投资收益减少。
    3、报告期内,现金流量表项目大幅度变动原因分析:

        项目            2007年1-3月         2006年1-3月            增减额         增减比例
 经营活动产生的现金
                           -78,844,905.87       -49,387,684.82     -29,457,221.05      -59.64%
      流量净额

    ⑴经营活动产生的现金流量净额同比减少59.64%,主要原因系本期购货支出同比大幅增加,现金流量净额减少额约占购货支出增加额的2.1%。
    3.2重大事项进展情况及其影响和解决方案的分析说明
    √适用□不适用
    关于上海华源长富药业(集团)有限公司问题(详见公司2007年年度报告)的情况进展:
    至本报告发布之日,公司尚未收到上海华源长富药业(集团)有限公司提供的该司2007年度审计报告。公司对该司的有关诉讼正在准备之中。
    公司还与该司及其控股股东就解决该司资产减值对上海医药的影响进行了新的沟通。
    3.3公司、股东及实际控制人承诺事项履行情况
    √适用□不适用

 股东名称    特殊承诺                                              承诺履行情况
             ①自股权分置改革方案实施之日2006年7月17日起,上
             海医药(集团)有限公司所持原非流通股股份在二十四个
             月内不上市交易或者转让;                              截至本报告期末,上海医药
 上海医药
             ②在前项规定期满后,上海医药(集团)有限公司通过证    (集团)有限公司所持本公
 (集团)有
             券交易所挂牌交易出售原非流通股股份,出售数量占公司    司股份处于限售期未上市
 限公司
             股份总数的比例在十二个月内不超过百分之五,在二十四    流通。
             个月内不超过百分之十。

    3.4预测年初至下一报告期期末的累计净利润可能为亏损或者与上年同期相比发生大幅度变动的警示及原因说明
    □适用√不适用
    3.5证券投资情况
    √适用□不适用

                                                                                    单位:元
 序    证券代               期末持有数量
                证券简称                    初始投资金额      期末账面值      会计核算科目
 号      码                    (股)
 1    601988    中国银行        1,210,000        6,100,820      6,062,100   交易性金融资产
 2    600018    上港集团          699,975        5,462,605      4,857,826   交易性金融资产
 3    000022    深赤湾A          130,000        3,400,540      2,197,000   交易性金融资产
 4    600717    天津港            106,600        2,681,949      2,166,112   交易性金融资产
 5    000039    中集集团          110,000        2,730,420      2,121,900   交易性金融资产
 6    002022    科华生物           50,000        1,879,650      1,696,500   交易性金融资产
 7    601939    建设银行          220,000        1,819,840      1,498,200   交易性金融资产
 8    000338    潍柴动力           17,000        1,440,206      1,087,830   交易性金融资产
 9    601398    工商银行          100,000          629,400        613,000   交易性金融资产
 10   601088    中国神华           12,000          443,880        480,000   交易性金融资产
           合计                  -             26,589,310     22,780,468          -
                                                                     上海市医药股份有限公司
                                                                           法定代表人:钱◇
                                                                            2008年4月26日

    4附录
    4.1                                   合并资产负债表

                                      2008年3月31日
编制单位:上海市医药股份有限公司
                                                  单位:元币种:人民币审计类型:未经审计
             项目                          期末余额                       年初余额
 流动资产:
 货币资金                                      871,819,029.34                 629,403,713.66
 结算备付金
 拆出资金
 交易性金融资产                                 36,011,010.11                  35,830,531.09
 应收票据                                        41,580,217.81                32,842,124.69
 应收账款                                     2,897,111,068.22             2,214,456,718.25
 预付款项                                      174,801,914.45                 346,216,429.03
 应收保费
 应收分保账款
 应收分保合同准备金
 应收利息
 应收股利                                        6,309,722.10                   1,665,664.88
 其他应收款                                     199,222,036.08               155,977,973.44
 买入返售金融资产
 存货                                        1,406,873,252.43               1,364,247,273.37
 一年内到期的非流动资产
 其他流动资产                                                -                    55,966.67
 流动资产合计                                5,633,728,250.54               4,780,696,395.08
 非流动资产:
 发放贷款及垫款
 可供出售金融资产                                3,642,644.08                   3,642,644.08
 持有至到期投资
 长期应收款                                     50,000,000.00                  50,000,000.00
 长期股权投资                                   307,337,222.13               331,823,088.26
 投资性房地产                                   251,936,302.04               253,577,913.84
 固定资产                                    1,044,377,248.45               1,051,951,004.11
 在建工程                                        85,297,628.66                77,583,541.30
 工程物资
 固定资产清理                                       -6,000.00                              -
 生产性生物资产
 油气资产
 无形资产                                       525,700,025.45               526,152,041.40
 开发支出
 商誉
 长期待摊费用                                    19,734,330.46                21,056,169.79
 递延所得税资产                                  29,314,179.38                29,115,535.36
 其他非流动资产
 非流动资产合计                               2,317,333,580.65             2,344,901,938.14
 资产总计                                    7,951,061,831.19               7,125,598,333.22

 流动负债:
 短期借款                                    2,179,187,625.78              1,999,462,039.44
 向中央银行借款
 吸收存款及同业存放
 拆入资金
 交易性金融负债
 应付票据                                      401,418,316.18                352,940,825.07
 应付账款                                    2,675,314,152.25              2,336,755,555.13
 预收款项                                       35,132,070.61                155,568,854.98
 卖出回购金融资产款
 应付手续费及佣金
 应付职工薪酬                                   49,454,614.10                 51,944,369.87
 应交税费                                       27,507,901.92                   -374,584.11
 应付利息                                        6,723,781.79                  6,170,197.72
 应付股利                                       22,512,399.12                  9,828,544.01
 其他应付款                                    518,664,120.46                214,260,630.74
 应付分保账款
 保险合同准备金
 代理买卖证券款
 代理承销证券款
 一年内到期的非流动负债
 其他流动负债
 流动负债合计                                5,915,914,982.21              5,126,556,432.85
 非流动负债:
 长期借款                                        1,640,000.00                  2,962,500.00
 应付债券
 长期应付款                                     34,143,851.83                 32,821,177.88
 专项应付款                                      2,506,961.83                  2,415,604.78
 预计负债
 递延所得税负债                                  2,571,546.40                  2,571,546.40
 其他非流动负债
 非流动负债合计                                 40,862,360.06                 40,770,829.06
 负债合计                                    5,956,777,342.27              5,167,327,261.91
 所有者权益(或股东权益):
 实收资本(或股本)                            569,172,884.00                569,172,884.00
 资本公积                                      579,263,741.50                579,263,741.50
 减:库存股
 盈余公积                                      226,758,627.32                226,758,627.32
 一般风险准备
 未分配利润                                    288,443,319.75                263,037,509.19
 外币报表折算差额                                2,043,129.23                  3,184,352.91
 归属于母公司所有者权益合计                  1,665,681,701.80              1,641,417,114.92
 少数股东权益                                  328,602,787.12                316,853,956.39
 所有者权益合计                              1,994,284,488.92              1,958,271,071.31
 负债和所有者总计                            7,951,061,831.19              7,125,598,333.22
公司法定代表人:钱◇   主管会计工作负责人:余金琦   会计机构负责人:许薇薇


                                      母公司资产负债表
                                      2008年3月31日
编制单位:上海市医药股份有限公司
                                                  单位:元币种:人民币审计类型:未经审计
              项目                          期末余额                      年初余额
 流动资产:
 货币资金                                       200,752,030.70                41,871,776.04
 交易性金融资产
 应收票据                                        24,197,995.60                10,685,126.65
 应收账款                                     1,342,317,984.48             1,036,892,673.41
 预付款项                                        38,424,795.66               198,326,048.68
 应收利息
 应收股利                                           599,289.56                   599,289.56
 其他应收款                                   1,060,743,396.10               968,691,166.77
 存货                                           619,269,295.60               617,534,463.22
 一年内到期的非流动资产
 其他流动资产
 流动资产合计                                 3,286,304,787.70             2,874,600,544.33
 非流动资产:
 可供出售金融资产                                 3,642,644.08                 3,642,644.08
 持有至到期投资
 长期应收款
 长期股权投资                                 1,329,343,828.94             1,327,566,500.28
 投资性房地产                                   187,815,450.19               189,345,954.13
 固定资产                                       508,049,953.68               508,369,534.99
 在建工程                                         2,389,792.24                 2,785,555.00
 工程物资
 固定资产清理
 生产性生物资产
 油气资产
 无形资产                                        65,004,745.28                65,598,745.04
 开发支出
 商誉
 长期待摊费用                                       118,305.00                   193,022.50
 递延所得税资产                                  18,846,148.25                18,846,148.25
 其他非流动资产
 非流动资产合计                               2,115,210,867.66             2,116,348,104.27
 资产总计                                     5,401,515,655.36             4,990,948,648.60
 流动负债:
 短期借款                                     1,882,000,000.00             1,732,000,000.00
 交易性金融负债
 应付票据                                       383,046,229.01               331,982,228.80
 应付账款                                     1,000,438,159.68             1,001,391,444.23
 预收款项                                        12,553,403.56               110,660,959.04

 应付职工薪酬                                     1,493,820.98                 3,414,028.88
 应交税费                                         2,395,730.61                -1,482,198.28
 应付利息                                         3,560,267.92                 3,068,745.95
 应付股利
 其他应付款                                     421,567,706.18               120,601,858.99
 一年内到期的非流动负债
 其他流动负债
 流动负债合计                                 3,707,055,317.94             3,301,637,067.61
 非流动负债:
 长期借款
 应付债券
 长期应付款                                      24,031,413.74                24,031,413.74
 专项应付款
 预计负债
 递延所得税负债                                     574,090.22                   574,090.22
 其他非流动负债
 非流动负债合计                                  24,605,503.96                24,605,503.96
 负债合计                                     3,731,660,821.90             3,326,242,571.57
 所有者权益(或股东权益):
 实收资本(或股本)                             569,172,884.00               569,172,884.00
 资本公积                                       548,098,602.72               548,098,602.72
 减:库存股
 盈余公积                                       226,758,627.32               226,758,627.32
 未分配利润                                     325,824,719.42               320,675,962.99
 所有者权益(或股东权益)合计                 1,669,854,833.46             1,664,706,077.03
 负债和所有者(或股东权益)合计               5,401,515,655.36             4,990,948,648.60
公司法定代表人:钱◇   主管会计工作负责人:余金琦   会计机构负责人:许薇薇

    4.2

                                         合并利润表
                                       2008年1-3月
                                                  单位:元币种:人民币审计类型:未经审计
                    项目                              本期金额               上期金额
 一、营业总收入                                      4,052,646,555.86      3,124,821,250.04
 其中:营业收入                                      4,052,646,555.86      3,124,821,250.04
 利息收入
 已赚保费
 手续费及佣金收入
 二、营业总成本                                      4,002,662,376.35       3,086,245,863.32
 其中:营业成本                                      3,689,912,131.78      2,868,691,614.73
 利息支出
 手续费及佣金支出
 退保金
 赔付支出净额
 提取保险合同准备金净额
 保单红利支出
 分保费用
 营业税金及附加                                          6,653,905.40          5,970,470.21
 销售费用                                              201,925,287.92         120,105,342.38
 管理费用                                               74,744,040.30          65,989,257.34
 财务费用                                               31,703,163.65         36,797,244.03
 资产减值损失                                              926,025.21                      -
 加:公允价值变动收益(损失以“-”号填列)
 投资收益(损失以“-”号填列)                          3,202,177.91         11,308,065.37
 其中:对联营企业和合营企业的投资收益
 汇兑收益(损失以“-”号填列)
 三、营业利润(亏损以“-”号填列)                     49,984,179.51         38,575,386.72
 加:营业外收入                                          1,016,509.42           3,457,611.81
 减:营业外支出                                            942,966.45            861,902.75
 其中:非流动资产处置净损失
 四、利润总额(亏损总额以“-”号填列)                 50,057,722.48          41,171,095.78
 减:所得税费用                                         12,903,081.19          8,442,176.86
 五、净利润(净亏损以“-”号填列)                     37,154,641.29          32,728,918.92
 归属于母公司所有者的净利润                             25,405,810.56          25,206,356.04
 少数股东损益                                           11,748,830.73          7,522,562.89
 六、每股收益:
 (一)基本每股收益                                              0.04                  0.05
 (二)稀释每股收益                                              0.04                   0.05
公司法定代表人:钱◇   主管会计工作负责人:余金琦   会计机构负责人:许薇薇


                                        母公司利润表
                                       2008年1-3月
                                                  单位:元币种:人民币审计类型:未经审计
                     项目                             本期金额               上期金额
 一、营业收入                                        2,154,619,511.39      1,718,793,568.23
 减:营业成本                                        2,018,591,076.89      1,606,648,017.11
 营业税金及附加                                          2,336,473.74          2,134,729.47
 销售费用                                               85,671,709.79         59,741,349.52
 管理费用                                               17,064,742.44         12,801,139.86
 财务费用                                               27,108,007.70         32,458,032.23
 资产减值损失
 加:公允价值变动收益(损失以“-”号填列)
 投资收益(损失以“-”号填列)                          2,127,328.66          1,876,425.34
 其中:对联营企业和合营企业的投资收益
 二、营业利润(亏损以“-”号填列)                      5,974,829.49          6,886,725.38
 加:营业外收入                                             30,307.00              6,973.00
 减:营业外支出                                            116,310.55             41,713.98
 其中:非流动资产处置净损失
 三、利润总额(亏损总额以“-”号填列)                  5,888,825.94          6,851,984.40
 减:所得税费用                                            740,069.51            798,833.86
 四、净利润(净亏损以“-”号填列)                      5,148,756.43          6,053,150.54
公司法定代表人:钱◇   主管会计工作负责人:余金琦   会计机构负责人:许薇薇

    4.3

                                       合并现金流量表
                                       2008年1-3月
                                                  单位:元币种:人民币审计类型:未经审计
                         项目                               本期金额           上期金额
 一、经营活动产生的现金流量:
 销售商品、提供劳务收到的现金                           5,031,950,903.77   3,632,018,212.06
 客户存款和同业存放款项净增加额
 向中央银行借款净增加额
 向其他金融机构拆入资金净增加额
 收到原保险合同保费取得的现金
 收到再保险业务现金净额
 保户储金及投资款净增加额
 处置交易性金融资产净增加额
 收取利息、手续费及佣金的现金
 拆入资金净增加额
 回购业务资金净增加额
 收到的税费返还                                            34,325,194.58      16,511,681.48
 收到其他与经营活动有关的现金                                4,984,237.65        413,027.66
 经营活动现金流入小计                                   5,071,260,336.00   3,648,942,921.20
 购买商品、接受劳务支付的现金                            4,877,226,408.60  3,498,954,282.10
 客户贷款及垫款净增加额
 存放中央银行和同业款项净增加额
 支付原保险合同赔付款项的现金
 支付利息、手续费及佣金的现金
 支付保单红利的现金
 支付给职工以及为职工支付的现金                            141,139,811.51     79,702,521.44
 支付的各项税费                                           107,424,589.91      97,780,075.75
 支付其他与经营活动有关的现金                              24,314,431.85      21,893,726.73
 经营活动现金流出小计                                    5,150,105,241.87  3,698,330,606.02
 经营活动产生的现金流量净额                               -78,844,905.87     -49,387,684.82
 二、投资活动产生的现金流量:
 收回投资收到的现金                                         20,000,000.00        381,233.60
 取得投资收益收到的现金                                     1,274,849.25       9,710,237.58
 处置固定资产、无形资产和其他长期资产收回的现金净额         99,567,500.00     16,937,505.62
 处置子公司及其他营业单位收到的现金净额
 收到其他与投资活动有关的现金                                  37,500.00           8,370.41
 投资活动现金流入小计                                      120,879,849.25     27,037,347.21
 购建固定资产、无形资产和其他长期资产支付的现金            26,757,220.73      14,973,795.07
 投资支付的现金                                             20,186,499.02        174,328.25
 质押贷款净增加额
 取得子公司及其他营业单位支付的现金净额
 支付其他与投资活动有关的现金                                           -         11,533.61
 投资活动现金流出小计                                       46,943,719.75     15,159,656.93
 投资活动产生的现金流量净额                                73,936,129.50      11,877,690.28

 三、筹资活动产生的现金流量:
 吸收投资收到的现金                                        20,000,000.00                   -
 其中:子公司吸收少数股东投资收到的现金
 取得借款收到的现金                                       268,403,086.34     205,900,000.00
 发行债券收到的现金
 收到其他与筹资活动有关的现金                                 262,576.67         122,236.52
 筹资活动现金流入小计                                     288,665,663.01      206,022,236.52
 偿还债务支付的现金
 分配股利、利润或偿付利息支付的现金                        44,327,717.33      32,580,118.03
 其中:子公司支付给少数股东的股利、利润
 支付其他与筹资活动有关的现金                               1,764,504.48          607,658.11
 筹资活动现金流出小计                                      46,092,221.81      33,187,776.14
 筹资活动产生的现金流量净额                               242,573,441.20      172,834,460.38
 四、汇率变动对现金及现金等价物的影响                       4,750,650.85      -5,003,559.08
 五、现金及现金等价物净增加额                             242,415,315.68     130,320,906.76
 加:期初现金及现金等价物余额                             629,403,713.66      534,755,148.77
 六、期末现金及现金等价物余额                             871,819,029.34     665,076,055.53
公司法定代表人:钱◇   主管会计工作负责人:余金琦   会计机构负责人:许薇薇


                                      母公司现金流量表
                                       2008年1-3月
                                                  单位:元币种:人民币审计类型:未经审计
                         项目                               本期金额           上期金额
 一、经营活动产生的现金流量:
 销售商品、提供劳务收到的现金                            2,405,366,018.72   1,773,515,655.91
 收到的税费返还                                             32,830,162.84      16,455,044.48
 收到其他与经营活动有关的现金                                4,554,537.43          47,116.31
 经营活动现金流入小计                                    2,442,750,718.99   1,790,017,816.70
 购买商品、接受劳务支付的现金                            2,443,742,273.45   1,775,197,635.88
 支付给职工以及为职工支付的现金                             55,983,623.44      36,376,161.42
 支付的各项税费                                             44,367,387.10      37,359,670.19
 支付其他与经营活动有关的现金                               16,150,496.40     -41,127,121.00
 经营活动现金流出小计                                    2,560,243,780.39   1,807,806,346.49
 经营活动产生的现金流量净额                               -117,493,061.40     -17,788,529.79
 二、投资活动产生的现金流量:
 收回投资收到的现金                                                     -                  -
 取得投资收益收到的现金                                        350,000.00       8,169,417.12
 处置固定资产、无形资产和其他长期资产收回的现金净额         99,100,000.00        168,607.84
 处置子公司及其他营业单位收到的现金净额                                 -                  -
 收到其他与投资活动有关的现金                                           -                  -
 投资活动现金流入小计                                       99,450,000.00       8,338,024.96
 购建固定资产、无形资产和其他长期资产支付的现金              5,991,173.68       5,532,505.06
 投资支付的现金                                             20,000,000.00                  -
 取得子公司及其他营业单位支付的现金净额                                 -                  -
 支付其他与投资活动有关的现金                                           -                  -
 投资活动现金流出小计                                       25,991,173.68       5,532,505.06
 投资活动产生的现金流量净额                                 73,458,826.32       2,805,519.90
 三、筹资活动产生的现金流量:
 吸收投资收到的现金                                                     -                  -
 取得借款收到的现金                                        240,000,000.00     172,000,000.00
 收到其他与筹资活动有关的现金                                           -                  -
 筹资活动现金流入小计                                      240,000,000.00     172,000,000.00
 偿还债务支付的现金                                                     -                  -
 分配股利、利润或偿付利息支付的现金                         37,085,510.26      28,526,605.90
 支付其他与筹资活动有关的现金                                           -           5,763.01
 筹资活动现金流出小计                                       37,085,510.26      28,532,368.91
 筹资活动产生的现金流量净额                                202,914,489.74     143,467,631.09
 四、汇率变动对现金及现金等价物的影响                                   -                  -
 五、现金及现金等价物净增加额                              158,880,254.66     128,484,621.20
 加:期初现金及现金等价物余额                               41,871,776.04     152,333,108.39
 六、期末现金及现金等价物余额                              200,752,030.70     280,817,729.59
公司法定代表人:钱◇   主管会计工作负责人:余金琦   会计机构负责人:许薇薇
数据加载中...
prevnext
手机查看股票